Q1 2022 financial results
Company: Core Scientific
The claim, verbatim
Core Scientific reported Q1 2022 revenue of $192.5 million, gross profit of $70.0 million, and adjusted EBITDA of $93.0 million.
Source (primary)
Core Scientific, Inc. — Entry #1842: Adversary case 22-03345 (RECAP (purchased via PACER), court_filing)
View cached copy (2026-09-26)Live source ↗
Quote: “Total revenue increased by 255% to $192.5 million • Gross profit increased by 382% to $70.0 million”
How we checked this
Checked on September 28, 2026. The cited source supports every part of this claim.
The complaint quotes Core Scientific's May 12, 2022 press release reporting these first-quarter 2022 figures.
Confirmed in the source:
- Q1 2022 revenue was $192.5 million
- Q1 2022 gross profit was $70.0 million
- Q1 2022 adjusted EBITDA was $93.0 million
What we did: Read our cached copy of RECAP (purchased via PACER) (https://storage.courtlistener.com/recap/gov.uscourts.txsb.460090/gov.uscourts.txsb.460090.1842.0.pdf) in full (60,424 characters, retrieved September 26, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific, Inc. — Entry #1842: Adversary case 22-03345
Quote: “Total revenue increased by 255% to $192.5 million • Gross profit increased by 382% to $70.0 million”